Petounis A, Papapanos G, Karageorgiou-Makromihelaki C
Br J Ophthalmol. 1978 Sep;62(9):660-2. doi: 10.1136/bjo.62.9.660.
Tobramycin sulphate, a new aminoglycoside antibiotic, was injected intramuscularly (80 and 100 mg) and subconjunctivally (10 mg) into patients, and the concentrations of the drug in serum and aqueous humour were determined 1 hour after the injection by an agar wall diffusion plate method. The intramuscular administration of tobramycin produced insignificant and non-inhibitory concentrations in the aqueous humour, while therapeutically effective levels of the antibiotic appeared in the aqueous after subconjunctival administrationof tobramycin (mean: 18.9 microgram/ml). These data suggest that tobramycin sulphate may be of value in the treatment of ocular infections.
硫酸妥布霉素是一种新型氨基糖苷类抗生素,分别以80毫克和100毫克的剂量给患者肌内注射,以10毫克的剂量给患者结膜下注射,注射1小时后,采用琼脂壁扩散平板法测定血清和房水中该药物的浓度。肌内注射妥布霉素后,房水中的药物浓度无显著变化且无抑菌作用,而结膜下注射妥布霉素后,房水中出现了治疗有效的抗生素水平(平均:18.9微克/毫升)。这些数据表明硫酸妥布霉素可能对眼部感染的治疗有价值。